| |
 |
|
Class Information
Number: 514/356
Name: Drug, bio-affecting and body treating compositions > Designated organic active ingredient containing (doai) > Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., o,s,se or te) or nitrogen as the only ring hetero atoms doai > Hetero ring is six-membered consisting of one nitrogen and five carbon atoms > C=o bonded directly to the six-membered hetero ring > At 3-position > C=o in a c(=o)o group (e.g., nicotinic acid, etc.)
Description: Subject matter wherein the C=O is part of aO group.
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 6936625 |
Amlodipine camsylate and method for preparing thereof |
Aug. 30, 2005 |
| 6924299 |
Methods and compositions useful in enhancing oxygen delivery to cells |
Aug. 2, 2005 |
| 6919087 |
Pharmaceutical compositions comprising amlodipine maleate |
Jul. 19, 2005 |
| 6908925 |
Treating skin wrinkles/fine lines with calcium channel inhibitors |
Jun. 21, 2005 |
| 6903118 |
Piperazinyl-substituted pyridylalkane, alkene and alkine carboxamides |
Jun. 7, 2005 |
| 6903124 |
Organic acid salt of amlodipine |
Jun. 7, 2005 |
| 6890944 |
Organic acid salt of amlodipine |
May. 10, 2005 |
| 6890958 |
Combinations of cholesteryl ester transfer protein inhibitors and nicotinic acid derivatives for cardiovascular indications |
May. 10, 2005 |
| 6878704 |
Heterocyclic mutilin esters and their use as antibacterials |
Apr. 12, 2005 |
| 6869914 |
Process for the preparation of solvent-free suspensions |
Mar. 22, 2005 |
| 6867236 |
Method of preventing of delaying the onset and progression of Alzheimer's disease and related disorders |
Mar. 15, 2005 |
| 6863904 |
Compositions and methods for prophylactic and therapeutic supplementation of nutrition in subjects |
Mar. 8, 2005 |
| 6852742 |
1,4-dihydropyridine and pyridine compounds as calcium channel blockers |
Feb. 8, 2005 |
| 6846826 |
Phenoxypropanol connected with phenylpiperazine and phenoxyalkylamine terminal in its side chain |
Jan. 25, 2005 |
| 6841173 |
Compositions and methods directed towards sore muscles and joints |
Jan. 11, 2005 |
| 6835742 |
Synergistic effect of amlodipine and atorvastatin on cholesterol crystal formation inhibition and aortic endothelial cell nitric oxide release |
Dec. 28, 2004 |
| 6833378 |
Corticotropin releasing factor antagonists |
Dec. 21, 2004 |
| 6830764 |
Method for denaturing allergens |
Dec. 14, 2004 |
| 6828337 |
Selective retinoid agonists |
Dec. 7, 2004 |
| 6828339 |
Amlodipine salt forms and processes for preparing them |
Dec. 7, 2004 |
| 6818200 |
Method of using deuterated calcium channel blockers |
Nov. 16, 2004 |
| 6809113 |
Antagonists of MCP-1 function and methods of use thereof |
Oct. 26, 2004 |
| 6800619 |
Caspase inhibitors and uses thereof |
Oct. 5, 2004 |
| 6794399 |
1,4-dihydropyridine derivative with a guaiacoxypropanolamine and/or phenoxypropanolamine moiety |
Sep. 21, 2004 |
| 6774111 |
Carbohydrate system and a method for providing nutrition to a diabetic |
Aug. 10, 2004 |
| 6753338 |
Methods for treating hypertension, angina, and congestive heart failure using of optically pure (-) amlodipine |
Jun. 22, 2004 |
| 6750234 |
Methods for increasing leptin levels using nicotinic acid compounds |
Jun. 15, 2004 |
| 6743770 |
Nutritional supplement for the management of stress |
Jun. 1, 2004 |
| 6726894 |
Transport vehicles for macromolecules |
Apr. 27, 2004 |
| 6727237 |
Inhibitors of bacterial NAD synthetase |
Apr. 27, 2004 |
| 6723730 |
Capsaicin receptor ligands |
Apr. 20, 2004 |
| 6716421 |
Devices and methods for eliminating termite colonies |
Apr. 6, 2004 |
| 6716457 |
Effects of bactericide (peracetic acid-hydrogen peroxide-water combination) to agricultural chemicals in bacteria control when they are in contact with one another |
Apr. 6, 2004 |
| 6716858 |
Methods for inhibiting diabetic complications |
Apr. 6, 2004 |
| 6713467 |
Acid derivatives useful as serine protease inhibitors |
Mar. 30, 2004 |
| 6713469 |
Chromium picolinate compositions and uses thereof |
Mar. 30, 2004 |
| 6699892 |
Pharmaceutically acceptable salt of amlodipine and method of preparing the same |
Mar. 2, 2004 |
| 6699853 |
4-HALOALKYL-3-HETEROCYCLYLPYRIDINES, 4-HALOALKYL-5-HETEROCYCLYL-PYRIMIDINES AND 4-TRIFLUOROMETHYL-3-OXADIAZOLYLPYRIDINES, PROCESSES FOR THEIR PREPARATION, COMPOSITIONS COMPRISING THEM, AND THE |
Mar. 2, 2004 |
| 6696083 |
Vitamin/nutrient dosage regimentation |
Feb. 24, 2004 |
| 6693129 |
Compositions and methods for lowering plasma lipoprotein(A) and risk factors of cardiovascular diseases |
Feb. 17, 2004 |
| 6677361 |
Topical formulations for the transdermal delivery of niacin and methods of treating hyperlipidemia |
Jan. 13, 2004 |
| 6660308 |
Beverage and additive for the ill |
Dec. 9, 2003 |
| 6660755 |
Substituted diaryl or diheteroaryl methans, ethers and amines having retinoid agonist, antagonist or inverse agonist type biological activity |
Dec. 9, 2003 |
| 6653326 |
Hydroxylamine derivatives useful for enhancing the molecular chaperon production and the preparation thereof |
Nov. 25, 2003 |
| 6646008 |
Treatment of disease states which result from neoplastic cell proliferation using PPAR-.gamma. activators and compositions useful therefor |
Nov. 11, 2003 |
| 6630494 |
Phenyl-substituted 1,4-dihydropyridines |
Oct. 7, 2003 |
| 6624178 |
Compounds for the management of aging-related and diabetic vascular complications, process for their preparation and therapeutic uses thereof |
Sep. 23, 2003 |
| 6624138 |
Drug-loaded biological material chemically treated with genipin |
Sep. 23, 2003 |
| 6610746 |
Synergistic effect of a sulfonylurea and/or non-sulfonylurea K+ATP channel blocker, and a phosphodiesterase 3 type inhibitor |
Aug. 26, 2003 |
| 6608094 |
Compounds for the management of aging-related and diabetic vascular complications, process for their preparation and therapeutic uses thereof |
Aug. 19, 2003 |
|
|
|
